Quote | Allarity Therapeutics Inc. (NASDAQ:ALLR)
Last: | $1.3782 |
---|---|
Change Percent: | -5.6% |
Open: | $1.48 |
Close: | $1.46 |
High: | $1.5 |
Low: | $1.35 |
Volume: | 338,156 |
Last Trade Date Time: | 04/29/2024 03:00:00 am |
News | Allarity Therapeutics Inc. (NASDAQ:ALLR)
2024-04-29 09:21:40 ET More on Allarity Therapeutics Allarity Therapeutics receives Nasdaq-approved extension to regain compliance Seeking Alpha’s Quant Rating on Allarity Therapeutics Historical earnings data for Allarity Therapeutics Financial inform...
Boston (April 29, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that on April 27, 2024, it received formal notic...
Message Board Posts | Allarity Therapeutics Inc. (NASDAQ:ALLR)
Subject | By | Source | When |
---|---|---|---|
It looks like its working out fine lmfao | INFINITI | investorshub | 07/05/2023 2:51:31 PM |
Hahaha what you think now | INFINITI | investorshub | 07/05/2023 2:51:07 PM |
AALR no 1 on the Barchart Top 100 | Monksdream | investorshub | 07/05/2023 2:47:34 PM |
https://finance.yahoo.com/news/initial-data-allarity-phase-2-134500446.html | surf1944 | investorshub | 07/05/2023 2:29:01 PM |
Its holding strong | INFINITI | investorshub | 06/29/2023 4:58:32 PM |
News, Short Squeeze, Breakout and More Instantly...
Allarity Therapeutics Inc. Company Name:
ALLR Stock Symbol:
NASDAQ Market:
Boston (April 29, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that on April 27, 2024, it received formal notic...
Boston (April 17, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that it had been granted an extension until May 14...
Shares of Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced that it sold its...